File Download
  Links for fulltext
     (May Require Subscription)
Supplementary

Conference Paper: Magnetic resonance imaging/ultrasound fusion guided prostate biopsy detects more clinically significant prostate cancer than conventional systematic biopsy method

TitleMagnetic resonance imaging/ultrasound fusion guided prostate biopsy detects more clinically significant prostate cancer than conventional systematic biopsy method
Authors
Ma, WKWong, CKWWong, JKWHo, BSHChan, YSLai, ASHLam, KCYip, LKCNg, ATLTsu, HLJYiu, MK
Issue Date2016
PublisherWiley-Blackwell Publishing Asia. The Journal's web site is located at http://www.blackwellpublishing.com/journals/ASH
Citation
The 2016 Conjoint Scientific Congress of The Royal College of Surgeons of Edinburgh and College of Surgeons of Hong Kong (RCSEd/CSHK), Hong Kong, 17-18 September 2016. In Surgical Practice, 2016, v. 20 suppl. 2, p. 5, abstract no. FP6 How to Cite?
DOI: http://dx.doi.org/10.1111/1744-1633.12206
AbstractAIM: To investigate the outcome of multiparametric magnetic resonance imaging (mpMRI)/ transrectal ultrasound (TRUS) fusion-guided prostate biopsy using an elastic fusion system compared with conventional TRUS biopsy in the Chinese population. METHODS: From January 2015 to April 2016, 318 Chinese men with elevated serum prostate-specific antigen of ≤ 20 ng/mL undergoing prostate biopsy were reviewed. 68 had pre-biopsy multiparametric magnetic resonance imaging, of whom 57 men with 98 Prostate Imaging – Reporting and Data System (PIRADS) 2–5 lesions underwent fusion biopsy (targeted + 12-core template biopsy) using the ArtemisTM fusion platform system. The biopsy outcomes where compared with 11 imaging-negative and 250 patients without pre-biopsy imaging who had 12-core systematic biopsy …
DescriptionSession - Extra Free Paper: no. FP6
This free journal suppl. entitled: Special Issue: RCSEd/CSHK Conjoint Scientific Congress 2016, Making Wise Choices in Surgery, 17–18 September 2016, Aberdeen, Hong Kong
Persistent Identifierhttp://hdl.handle.net/10722/240136
ISSN
1744-1625
2013 Impact Factor: 0.172
2020 SCImago Journal Rankings: 0.109

 

DC FieldValueLanguage
dc.contributor.authorMa, WK-
dc.contributor.authorWong, CKW-
dc.contributor.authorWong, JKW-
dc.contributor.authorHo, BSH-
dc.contributor.authorChan, YS-
dc.contributor.authorLai, ASH-
dc.contributor.authorLam, KC-
dc.contributor.authorYip, LKC-
dc.contributor.authorNg, ATL-
dc.contributor.authorTsu, HLJ-
dc.contributor.authorYiu, MK-
dc.date.accessioned2017-04-13T02:23:53Z-
dc.date.available2017-04-13T02:23:53Z-
dc.date.issued2016-
dc.identifier.citationThe 2016 Conjoint Scientific Congress of The Royal College of Surgeons of Edinburgh and College of Surgeons of Hong Kong (RCSEd/CSHK), Hong Kong, 17-18 September 2016. In Surgical Practice, 2016, v. 20 suppl. 2, p. 5, abstract no. FP6-
dc.identifier.issn1744-1625-
dc.identifier.urihttp://hdl.handle.net/10722/240136-
dc.descriptionSession - Extra Free Paper: no. FP6-
dc.descriptionThis free journal suppl. entitled: Special Issue: RCSEd/CSHK Conjoint Scientific Congress 2016, Making Wise Choices in Surgery, 17–18 September 2016, Aberdeen, Hong Kong-
dc.description.abstractAIM: To investigate the outcome of multiparametric magnetic resonance imaging (mpMRI)/ transrectal ultrasound (TRUS) fusion-guided prostate biopsy using an elastic fusion system compared with conventional TRUS biopsy in the Chinese population. METHODS: From January 2015 to April 2016, 318 Chinese men with elevated serum prostate-specific antigen of ≤ 20 ng/mL undergoing prostate biopsy were reviewed. 68 had pre-biopsy multiparametric magnetic resonance imaging, of whom 57 men with 98 Prostate Imaging – Reporting and Data System (PIRADS) 2–5 lesions underwent fusion biopsy (targeted + 12-core template biopsy) using the ArtemisTM fusion platform system. The biopsy outcomes where compared with 11 imaging-negative and 250 patients without pre-biopsy imaging who had 12-core systematic biopsy …-
dc.languageeng-
dc.publisherWiley-Blackwell Publishing Asia. The Journal's web site is located at http://www.blackwellpublishing.com/journals/ASH-
dc.relation.ispartofSurgical Practice-
dc.rightsPreprint This is the pre-peer reviewed version of the following article: [FULL CITE], which has been published in final form at [Link to final article]. Authors are not required to remove preprints posted prior to acceptance of the submitted version. Postprint This is the accepted version of the following article: [full citation], which has been published in final form at [Link to final article].-
dc.titleMagnetic resonance imaging/ultrasound fusion guided prostate biopsy detects more clinically significant prostate cancer than conventional systematic biopsy method-
dc.typeConference_Paper-
dc.identifier.emailMa, WK: mwk054@hku.hk-
dc.identifier.emailWong, CKW: kwwongab@hku.hk-
dc.identifier.emailTsu, HLJ: jamestsu@hku.hk-
dc.identifier.emailYiu, MK: pmkyiu@hku.hk-
dc.description.naturelink_to_OA_fulltext-
dc.identifier.doi10.1111/1744-1633.12206-
dc.identifier.hkuros271862-
dc.identifier.volume20-
dc.identifier.issuesuppl. 2-
dc.identifier.spage5, abstract no. FP6-
dc.identifier.epage5, abstract no. FP6-
dc.publisher.placeAustralia-
dc.identifier.issnl1744-1625-

Export via OAI-PMH Interface in XML Formats

OR

Export to Other Non-XML Formats